Compare RCG & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCG | TXMD |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 24.3M |
| IPO Year | 1996 | 2012 |
| Metric | RCG | TXMD |
|---|---|---|
| Price | $3.00 | $2.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.1K | ★ 17.3K |
| Earning Date | 01-01-0001 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | N/A | $207.74 |
| Revenue Next Year | N/A | $2.15 |
| P/E Ratio | ★ N/A | $102.00 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $2.45 | $0.99 |
| 52 Week High | $3.31 | $2.95 |
| Indicator | RCG | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 39.02 |
| Support Level | $2.80 | $2.00 |
| Resistance Level | $3.00 | $2.15 |
| Average True Range (ATR) | 0.02 | 0.06 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 0.00 | 0.00 |
RENN Fund Inc is a registered, non-diversified, closed-end management investment company. Its investment objective is to provide shareholders with above-market rates of return through capital appreciation and income by a long-term, value oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities, including convertible and non-convertible debt securities or loans, distressed debt, warrants, preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. To a lesser extent, the fund sells short stocks, exchange-traded funds, and exchange-traded notes. It invests in various industries, including communication services, surgical and medical instruments, oil and gas, etc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.